219 related articles for article (PubMed ID: 28461642)
1. Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors.
Theander L; Nyhäll-Wåhlin BM; Nilsson JÅ; Willim M; Jacobsson LTH; Petersson IF; Turesson C
J Rheumatol; 2017 Jul; 44(7):981-987. PubMed ID: 28461642
[TBL] [Abstract][Full Text] [Related]
2. Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors.
Nyhäll-Wåhlin BM; Petersson IF; Jacobsson C; Geborek P; Nilsson JÅ; Nilsson K; Jacobsson LT; Turesson C
Scand J Rheumatol; 2012; 41(6):434-7. PubMed ID: 22813208
[TBL] [Abstract][Full Text] [Related]
3. Extra-articular rheumatoid arthritis.
Turesson C
Curr Opin Rheumatol; 2013 May; 25(3):360-6. PubMed ID: 23425964
[TBL] [Abstract][Full Text] [Related]
4. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.
Myasoedova E; Crowson CS; Turesson C; Gabriel SE; Matteson EL
J Rheumatol; 2011 Jun; 38(6):983-9. PubMed ID: 21459933
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.
Turesson C; O'Fallon WM; Crowson CS; Gabriel SE; Matteson EL
J Rheumatol; 2002 Jan; 29(1):62-7. PubMed ID: 11824973
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
Komano Y; Tanaka M; Nanki T; Koike R; Sakai R; Kameda H; Nakajima A; Saito K; Takeno M; Atsumi T; Tohma S; Ito S; Tamura N; Fujii T; Sawada T; Ida H; Hashiramoto A; Koike T; Ishigatsubo Y; Eguchi K; Tanaka Y; Takeuchi T; Miyasaka N; Harigai M;
J Rheumatol; 2011 Jul; 38(7):1258-64. PubMed ID: 21498482
[TBL] [Abstract][Full Text] [Related]
7. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.
Curtis JR; Sarsour K; Napalkov P; Costa LA; Schulman KL
Arthritis Res Ther; 2015 Nov; 17():319. PubMed ID: 26555431
[TBL] [Abstract][Full Text] [Related]
8. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.
Turesson C; O'Fallon WM; Crowson CS; Gabriel SE; Matteson EL
Ann Rheum Dis; 2003 Aug; 62(8):722-7. PubMed ID: 12860726
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.
Turesson C; Schaid DJ; Weyand CM; Jacobsson LT; Goronzy JJ; Petersson IF; Dechant SA; Nyähll-Wåhlin BM; Truedsson L; Sturfelt G; Matteson EL
Arthritis Rheum; 2006 Sep; 54(9):2776-83. PubMed ID: 16947780
[TBL] [Abstract][Full Text] [Related]
10. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
[TBL] [Abstract][Full Text] [Related]
11. Extraarticular manifestations of rheumatoid arthritis develop in patients receiving anti-tumor necrosis factor-α treatment: a retrospective chart review from a UK center.
Negoescu AF; Tennekone D; Soljak MA; Abraham SM
J Rheumatol; 2014 Oct; 41(10):1944-7. PubMed ID: 25179847
[TBL] [Abstract][Full Text] [Related]
12. Extra-articular manifestations of rheumatoid arthritis: a hospital-based study.
Al-Ghamdi A; Attar SM
Ann Saudi Med; 2009; 29(3):189-93. PubMed ID: 19448378
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
Guignard S; Gossec L; Bandinelli F; Dougados M
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
[TBL] [Abstract][Full Text] [Related]
14. Extra-articular rheumatoid arthritis: prevalence and mortality.
Turesson C; Jacobsson L; Bergström U
Rheumatology (Oxford); 1999 Jul; 38(7):668-74. PubMed ID: 10461483
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
16. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
17. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.
Turesson C; McClelland RL; Christianson TJ; Matteson EL
Ann Rheum Dis; 2007 Jan; 66(1):70-5. PubMed ID: 16877533
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P; Simard JF; Holmqvist M; Askling J;
BMJ; 2013 Apr; 346():f1939. PubMed ID: 23568792
[TBL] [Abstract][Full Text] [Related]
19. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Koo BS; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Korean J Intern Med; 2015 Jan; 30(1):104-9. PubMed ID: 25589842
[TBL] [Abstract][Full Text] [Related]
20. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
